Arbutus Biopharma Corporation (ABUS): correction ABUS ARBUTUS BIOPHARMA CORP...

Send PM Follow Ignore

Followers	4045
Posts	152977
Boards Moderated	3
Alias Born	08/05/2009

TheFinalCD

Re: alchemytrader post# 5320

Saturday, 07/25/2020 12:53:02 PM

Saturday, July 25, 2020 12:53:02 PM

correction
ABUS ARBUTUS BIOPHARMA CORP 6,900 --- 40,321.68 --- 40,025.29 -296.39

thought I caught the bottom

#FAIL

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ABUS News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 11:31:46 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 11:31:16 AM
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2026 11:30:00 AM
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/28/2026 09:54:41 PM
Arbutus Shares Jump After FDA Grants Fast Track Status to Hepatitis B Therapy • IH Market News • 04/15/2026 02:09:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 11:31:20 AM
Arbutus Receives U.S. FDA Fast Track Designation for Imdusiran for the Treatment of Chronic Hepatitis B • GlobeNewswire Inc. • 04/15/2026 11:30:00 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/14/2026 09:05:20 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/14/2026 09:02:17 PM
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/13/2026 11:56:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:31:10 AM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/23/2026 11:30:44 AM
Arbutus Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/23/2026 11:30:00 AM
Moderna agrees up to $2.25 billion settlement in COVID vaccine patent dispute • IH Market News • 03/04/2026 11:24:49 AM
Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With Moderna • GlobeNewswire Inc. • 03/03/2026 09:15:00 PM
Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna • GlobeNewswire Inc. • 03/03/2026 09:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 09:01:31 PM
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:21:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 09:01:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 01:21:34 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 01:21:13 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2026 12:41:46 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2025 01:00:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 12:31:34 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 12:31:10 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent ABUS News

More ABUS News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ABUS News

Go Ad-Free